» Articles » PMID: 23314380

MiR-34a Inhibits the Metastasis of Osteosarcoma Cells by Repressing the Expression of CD44

Overview
Journal Oncol Rep
Specialty Oncology
Date 2013 Jan 15
PMID 23314380
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

Osteosarcoma is the most common type of malignant bone tumor in children and adolescents and approximately 30% of patients develop lung metastasis, which is the leading cause of mortality. In this study, we investigated the role of miR-34a in the invasion and metastasis of osteosarcoma cells by examining its expression level and functional pattern in these cells. miR-34a mimics were transfected into the highly metastatic subline, F5M2, and into the F4 subline with low metastatic potential of the paired human osteosarcoma cell line, SOSP‑9607. Cell viability patterns, cell migration and alterations in gene expression levels were assessed by real-time PCR, and changes in protein levels were assessed by immunocytochemistry and western blot analysis. The ectopic overexpression of miR-34a significantly inhibited the migration and invasive ability of osteosarcoma cells by repressing the expression of CD44. These data suggest that miR-34a plays a tumor suppressor role in the metastasis of osteosarcoma cells by repressing the expression of CD44. Of note, studies have also suggested that the CD44 protein correlates with the metastatic potential of several malignant tumors. Therefore, it can be concluded that through the inhibition of CD44 expression levels, miR-34a plays a significant role in the migration and invasion of osteosarcoma cells.

Citing Articles

CD44 Modulates Cell Migration and Invasion in Ewing Sarcoma Cells.

Fernandez-Tabanera E, Garcia-Garcia L, Rodriguez-Martin C, Cervera S, Gonzalez-Gonzalez L, Robledo C Int J Mol Sci. 2023; 24(14).

PMID: 37511533 PMC: 10381016. DOI: 10.3390/ijms241411774.


Targeted therapy using nanocomposite delivery systems in cancer treatment: highlighting miR34a regulation for clinical applications.

Iqbal M, Javed Z, Sadia H, Mehmood S, Akbar A, Zahid B Cancer Cell Int. 2023; 23(1):84.

PMID: 37149609 PMC: 10164299. DOI: 10.1186/s12935-023-02929-3.


MicroRNA34a is associated with chemotherapy resistance, metastasis, recurrence, survival, and prognosis in patient with osteosarcoma.

Lian H, Zhou Y, Sun Z, Liu K Medicine (Baltimore). 2022; 101(38):e30722.

PMID: 36197268 PMC: 9509030. DOI: 10.1097/MD.0000000000030722.


CD44 In Sarcomas: A Comprehensive Review and Future Perspectives.

Fernandez-Tabanera E, Melero-Fernandez de Mera R, Alonso J Front Oncol. 2022; 12:909450.

PMID: 35785191 PMC: 9247467. DOI: 10.3389/fonc.2022.909450.


Mir-34a: a regulatory hub with versatile functions that controls osteosarcoma networks.

Yang Z, Liu T, Ren X, Yang M, Tu C, Li Z Cell Cycle. 2022; 21(20):2121-2131.

PMID: 35699451 PMC: 9519004. DOI: 10.1080/15384101.2022.2087755.